@FiercePharma: Steve Jobs might benefit from new cancer drugs. Report | Follow @FiercePharma
> Sinopharm, China's biggest drug distributor, plans to spend at least ¥5 billion ($759 million) buying companies in the next two years after agreeing to its largest acquisition since going public. Story
> Savient Pharmaceuticals named former Eli Lilly oncology executive John Johnson as its chief executive effective Jan. 31. Report
> John Horan, who served as chairman and CEO of Merck from 1976 to 1985 as the company grew to become the world's largest drugmaker, has died. He was 90. Item
> Mylan said it settled a patent dispute with Pfizer, which will enable it to sell the generic version of the blood pressure drug Caduet beginning Nov. 30. News
> Mitsubishi Tanabe Pharma said it will recall 2 million shots of three injected drugs made at a factory in Japan after an employee failed to test the medicines properly to ensure they met quality controls. Article
> Genzyme has voluntarily repaid $6 million in job-creation incentives to Massachusetts after failing to meet their terms. Report
> Bristol-Myers Squibb, which spent $885 million to acquire Seattle-based ZymoGenetics in October, has decided to maintain its presence there. Report
> The cost of Johnson & Johnson's string of recent McNeil product recalls, most notably those of children's medicines: about $900 million in lost sales in 2010. Item
> Most Americans do not want Congress to block funding for various new healthcare measures even as the nation remains split on the sweeping overhaul passed last year, a new poll found. Story
> Irish drugmaker Elan has quietly laid off 130 people, or about 10 percent of its workforce. Article
Biotech News
@FierceBiotech: Rogosin investigators use cancer to fight cancer. Item | Follow @FierceBiotech
@JohnCFierce: FYI, I'm headed to NY Feb 14-16 for the BIO investor forum; Milan for Bio-Europe March 14-16, sandwiched between a couple of webinars. Follow @JohnCFierce
> Data vs. market "exclusivity" in blockbuster scrap over biosimilars. Story
> Report: Elan chops San Francisco R&D in big shakeup. Item
> Sanofi's Viehbacher cites "progress" in takeover talks with Genzyme. Article
> Abbott chops 1,900 workers after experimental drugs flop. News
Drug Delivery News
> FDA issues guidance on maximum 'sprinkle drug' bead size. Story
> NanoPopcorn targets, cooks and tracks prostate cancer cells. Item
> Pacira licenses DepoFoam to Novo Nordisk, plans IPO. Article
> Government funding makes sense for early pharma research. Report
> Nano in the brain: Is it safe? Story
Medical Device News
> 3M, beleagured J&J, announce financial results. Story
> Abbott stent sales soar in Q4. Article
> CSA Medical snares $10M in first round. Story
> Abbott to ask FDA panel for expanded approval of carotid stent. News
> Stryker eyeing acquisitions. Report
> Shamed cardiologist's suit against med center transferred. Article
And Finally... German Health Minister Philipp Rösler sent a letter to the nation's drugmakers, asking them to refuse any requests from the U.S. for the drug sodium thiopental, which is used in lethal injections. News